Carson P - Search Results

1

Effect of Valsartan on hospitalization: results from Val-HeFT.

Carson P, Tognoni G, Cohn JN. Carson P, et al. J Card Fail. 2003 Jun;9(3):164-71. doi: 10.1054/jcaf.2003.22. J Card Fail. 2003. PMID: 12815565 Clinical Trial.

2

Cardiovascular and neurohormonal effects of atrial natriuretic peptide in conscious dogs with and without chronic left ventricular dysfunction.

Carson P, Carlyle P, Rector TS, Cohn JN. Carson P, et al. J Cardiovasc Pharmacol. 1990 Aug;16(2):305-11. doi: 10.1097/00005344-199008000-00018. J Cardiovasc Pharmacol. 1990. PMID: 1697388

3

Cardiac and regional vascular effects of atrial natriuretic peptide in awake dogs with left ventricular dysfunction.

Carson PE, Carlyle PF, Cohn JN. Carson PE, et al. Trans Assoc Am Physicians. 1986;99:34-8. Trans Assoc Am Physicians. 1986. PMID: 2955559 No abstract available.

4

The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.

Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. Carson PE, et al. Circulation. 1993 Jun;87(6 Suppl):VI102-10. Circulation. 1993. PMID: 8500233 Clinical Trial.

5

Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.

Johnson G, Carson P, Francis GS, Cohn JN. Johnson G, et al. Among authors: carson p. Circulation. 1993 Jun;87(6 Suppl):VI32-9. Circulation. 1993. PMID: 8500237 Clinical Trial.

6

Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.

Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn JN. Fletcher RD, et al. Among authors: carson p. Circulation. 1993 Jun;87(6 Suppl):VI49-55. Circulation. 1993. PMID: 8500239 Clinical Trial.

7

Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.

Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN. Dunkman WB, et al. Among authors: carson pe. Circulation. 1993 Jun;87(6 Suppl):VI94-101. Circulation. 1993. PMID: 8500246 Clinical Trial.

8

Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).

Carson P, Johnson G, Fletcher R, Cohn J. Carson P, et al. J Am Coll Cardiol. 1996 Mar 1;27(3):642-9. doi: 10.1016/0735-1097(95)00503-x. J Am Coll Cardiol. 1996. PMID: 8606276 Free article. Clinical Trial.

9

Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.

Boden WE, Ziesche S, Carson PE, Conrad CH, Syat D, Cohn JN. Boden WE, et al. Among authors: carson pe. Am J Cardiol. 1996 May 15;77(12):1078-82. doi: 10.1016/s0002-9149(96)00136-1. Am J Cardiol. 1996. PMID: 8644661 Clinical Trial.

10

Beta blocker treatment in heart failure.

Carson PE. Carson PE. Prog Cardiovasc Dis. 1999 Jan-Feb;41(4):301-21. doi: 10.1053/pcad.1999.0410301. Prog Cardiovasc Dis. 1999. PMID: 10362350 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

674 results

Search Page

Filters